CohBar Inc (CWBR)
0.7601
-0.04
(-5.11%)
USD |
OTCM |
May 09, 16:00
CohBar Net Income (TTM): -12.69M for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -12.69M |
March 31, 2023 | -11.08M |
December 31, 2022 | -12.18M |
September 30, 2022 | -11.17M |
June 30, 2022 | -12.20M |
March 31, 2022 | -14.70M |
December 31, 2021 | -15.48M |
September 30, 2021 | -17.39M |
June 30, 2021 | -17.21M |
March 31, 2021 | -16.09M |
December 31, 2020 | -16.26M |
September 30, 2020 | -15.27M |
June 30, 2020 | -15.39M |
March 31, 2020 | -14.34M |
December 31, 2019 | -13.04M |
September 30, 2019 | -13.52M |
June 30, 2019 | -14.78M |
March 31, 2019 | -15.04M |
Date | Value |
---|---|
December 31, 2018 | -15.71M |
September 30, 2018 | -14.35M |
June 30, 2018 | -12.60M |
March 31, 2018 | -11.19M |
December 31, 2017 | -9.833M |
September 30, 2017 | -8.677M |
June 30, 2017 | -7.470M |
March 31, 2017 | -7.091M |
December 31, 2016 | -6.075M |
September 30, 2016 | -5.548M |
June 30, 2016 | -4.974M |
March 31, 2016 | -4.313M |
December 31, 2015 | -3.878M |
September 30, 2015 | -3.223M |
June 30, 2015 | -2.552M |
March 31, 2015 | -2.346M |
December 31, 2014 | -1.820M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-17.39M
Minimum
Sep 2021
-11.08M
Maximum
Mar 2023
-14.28M
Average
-14.70M
Median
Mar 2022
Net Income (TTM) Benchmarks
Madrigal Pharmaceuticals Inc | -444.28M |
CymaBay Therapeutics Inc (DELISTED) | -105.37M |
Akero Therapeutics Inc | -151.76M |
89bio Inc | -142.19M |
Sagimet Biosciences Inc | -27.88M |